Core Viewpoint - H&H International Holdings (01112) reported a 12.0% year-on-year increase in total revenue for the nine months ending September 30, 2025, reaching RMB 10.805 billion, driven by strong growth in the infant nutrition and care products segment, particularly in infant formula milk powder, which saw a 33.3% increase [1][1][1] Group 1: Financial Performance - Total revenue increased by 12.0% year-on-year to RMB 10.805 billion, with a comparable basis increase of 12.3% [1][1][1] - The infant nutrition and care products segment experienced accelerated growth, with a 24.0% increase [1][1][1] - Infant formula milk powder business grew by 33.3% year-on-year [1][1][1] Group 2: Business Segment Insights - The infant probiotics and nutritional supplements segment saw a reduced decline of 2.3%, with a strong double-digit growth in the last three months of the reporting period [1][1][1] - The infant formula powder industry is currently under pressure due to demand factors, but H&H's sales in this segment increased by 10.0% year-on-year, outperforming the industry average [1][1][1] - Strong sales performance in Stage 1 and Stage 2 infant formula contributed to the company's growth [1][1][1] Group 3: Market Outlook - The ongoing implementation of childcare subsidy policies is expected to improve demand for infant formula, supporting continued growth for H&H's products [1][1][1] - The company’s infant probiotics and nutritional supplements are anticipated to gradually return to a growth trajectory [1][1][1]
H&H国际控股再涨超4% 公司婴幼儿相关产品增长势头加快 婴配粉销售远超行业平均水平